- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04073420
Medtronic Cardiac Surgery PMCF Registry
April 11, 2024 updated by: Medtronic Cardiac Surgery
Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry
This registry is being conducted to support ongoing post-market surveillance activities.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
2700
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lisa Slusser
- Phone Number: 1-800-328-2518
- Email: rs.hvtpmcfregistry@medtronic.com
Study Contact Backup
- Name: Jessica Halverson
- Phone Number: 1-800-328-2518
- Email: rs.hvtpmcfregistry@medtronic.com
Study Locations
-
-
-
Wien, Austria, 1090
- Recruiting
- Allgemeines Krankenhaus - Universitätskliniken Wien
-
Contact:
- Martin Andreas, Prof
-
-
-
-
-
Leuven, Belgium, 3000
- Recruiting
- UZ Leuven
-
Contact:
- Wouter Oosterlinck, Prof
-
-
-
-
-
Pessac, France, 33604
- Recruiting
- Hôpital Haut-Lévêque - CHU de Bordeaux
-
Contact:
- Louis Labrousse, Prof
-
-
-
-
-
Bad Rothenfelde, Germany, 49214
- Recruiting
- Schüchtermann-Klinik
-
Contact:
- Nicolas Doll, Prof
-
Dresden, Germany, 01307
- Recruiting
- Herzzentrum Dresden GmbH Universitätsklinik
-
Contact:
- Klaus Matschke, MD
-
Düsseldorf, Germany, 40225
- Recruiting
- Universitatsklinikum Dusseldorf
-
Contact:
- Payam Akhyari, Prof. Dr.
-
Hamburg, Germany, 22457
- Recruiting
- Albertinen-Herz- und Gefäßzentrum
-
Contact:
- Friedrich-Christian Reiss, Prof
-
Leipzig, Germany
- Recruiting
- Herzzentrum Leipzig
-
Contact:
- Michael Borger, MD
-
München, Germany, 80636
- Recruiting
- Deutsches Herzzentrum München Klinik an der TU München
-
Contact:
- Markus Krane, Prof
-
-
-
-
-
Athens, Greece, 17674
- Recruiting
- Onassis Cardiac Surgery Center
-
Contact:
- George Stavridis, MD
-
-
-
-
-
Massa, Italy, 54100
- Recruiting
- Ospedale Pasquinucci Massa
-
Contact:
- Marco Solinas, MD
-
San Donato, Italy
- Recruiting
- IRCCS Policlinico
-
Contact:
- Dr. Andrea Garatti
-
-
-
-
-
Leiden, Netherlands
- Recruiting
- Leids Universitair Medisch Centrum
-
Contact:
- Jerry Braun, MD
-
-
-
-
-
Málaga, Spain, 29010
- Recruiting
- Hospital Regional Universitario Carlos Haya Málaga - Hospital General
-
Contact:
- Enrique Ruiz Alonso, Dr.
-
-
-
-
-
Bern, Switzerland, 3010
- Recruiting
- Inselspital - Universitätsspital Bern
-
Contact:
- Matthias Siepe, Prof. Dr.
-
-
-
-
Georgia
-
Marietta, Georgia, United States, 30060
- Recruiting
- Wellstar Kennestone Hospital
-
Contact:
- Richard Myung, MD
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Recruiting
- University of Michigan
-
Contact:
- Bolling Steven, MD
-
-
New York
-
New York, New York, United States, 10029
- Recruiting
- Mount Sinai Medical Center
-
Contact:
- Ahmed El-Eshmawi, MD
-
Roslyn, New York, United States, 11576
- Recruiting
- Saint Francis Hospital
-
Contact:
- Newell Robinson, MD
-
Syracuse, New York, United States, 13203
- Recruiting
- Saint Josephs Hospital Health Center
-
Contact:
- Karikehalli Dilip, MD
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Recruiting
- Duke University Medical Center
-
Contact:
- Donald Glower, MD
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Recruiting
- University Hospitals Cleveland
-
Contact:
- Alan Markowitz, MD
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- University of Pittsburgh Medical Center UPMC Presbyterian
-
Contact:
- Johannes Bonatti, MD
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- Baylor St. Luke's Medical Center
-
Contact:
- Kenneth Liao, MD
-
Plano, Texas, United States, 75093
- Recruiting
- The Heart Hospital Plano
-
Contact:
- Timothy George, MD
-
-
Virginia
-
Falls Church, Virginia, United States, 22042
- Recruiting
- Inova
-
Contact:
- Eric Sarin, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Subjects requiring heart valve therapy replacement and/or repair.
Description
Inclusion Criteria:
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible product
- Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
Exclusion Criteria:
- Patient who is, or is expected to be, inaccessible for follow-up
- Patient prohibited from participation by local law
- Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Surgical Valve Replacement and/or Repair Patients
|
Surgical heart valve repair products.
Surgical heart valve replacement products.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identify unique failure modes
Time Frame: 10 years
|
10 years
|
Identify trends in adverse device effects
Time Frame: 10 years
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2019
Primary Completion (Estimated)
December 31, 2039
Study Completion (Estimated)
December 31, 2039
Study Registration Dates
First Submitted
August 19, 2019
First Submitted That Met QC Criteria
August 28, 2019
First Posted (Actual)
August 29, 2019
Study Record Updates
Last Update Posted (Estimated)
April 15, 2024
Last Update Submitted That Met QC Criteria
April 11, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MDT18061SUR003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Valve Disease, Heart
-
Boston Children's HospitalRecruitingValve Disease, Heart | Valve Heart Disease | Valve Disease, AorticUnited States
-
Caisson Interventional LLCActive, not recruitingMitral Regurgitation | Valve Disease, Heart | Valve Heart Disease | Mitral Valve Disease | Mitral Valve Failure | Mitral DiseaseUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingAortic Valve Disease | Heart Valve Diseases | Mitral Valve Disease | Tricuspid Valve DiseaseGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingAortic Valve Disease | Cardiac Valve Disease | Mitral Valve Disease | Tricuspid Valve DiseaseNetherlands
-
InnovHeartActive, not recruitingHeart Valve Diseases | Mitral Regurgitation | Valve Heart Disease | Mitral Valve Disease | Mitral DiseaseLithuania, Denmark, Hungary
-
Assistance Publique Hopitaux De MarseilleSuspendedAortic Valve Regurgitation AcquiredFrance
-
Azienda Ospedaliero-Universitaria CareggiRecruitingAortic Valve Stenosis | Aortic Valve Insufficiency | Valvular Heart Disease | Tricuspid Regurgitation | Mitral Valve DiseaseItaly
-
Washington University School of MedicineQuest Medical, IncRecruitingAortic Valve Disease | Mitral Valve DiseaseUnited States
-
Closed Joint-Stock Company NeoCorResearch Institute for Complex Problems of Cardiovascular Diseases, Russia; CT Medical Limited Liability CompanyRecruitingAortic Valve Disease | Mitral Valve DiseaseRussian Federation
-
Edwards LifesciencesWithdrawnCardiovascular Disease | Heart Disease | Heart Valve Disease | Mitral Insufficiency
Clinical Trials on Surgical Heart Valve Repair Products
-
Michele De BonisCompletedMitral Valve RegurgitationItaly
-
NeoChordRecruitingMitral Valve InsufficiencyUnited States
-
Southern Illinois UniversityWithdrawnMyocardial Infarction | Mitral RegurgitationUnited States
-
Edwards LifesciencesTerminatedMitral RegurgitationGermany, Netherlands, Austria, United Kingdom
-
Edwards LifesciencesActive, not recruitingMitral RegurgitationUnited States, Canada
-
Annetine GelijnsNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsCompletedAtrial Fibrillation | Mitral Valve Insufficiency | Mitral Valve StenosisUnited States, Canada
-
Edwards LifesciencesICON plcTerminatedSevere Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet ProlapseGermany, Spain, Switzerland
-
Maastricht University Medical CenterCompletedVentricular Septal Rupture | Papillary Muscle Rupture | Free Wall Rupture, HeartNetherlands
-
Ottawa Heart Institute Research CorporationRecruitingCoronary Artery Disease | Mitral Valve InsufficiencyCanada
-
Meshalkin Research Institute of Pathology of CirculationUnknownPulmonary HypertensionRussian Federation